Annual Working Capital
$281.02 M
+$57.05 M+25.47%
31 December 2023
Summary:
Verona Pharma annual working capital is currently $281.02 million, with the most recent change of +$57.05 million (+25.47%) on 31 December 2023. During the last 3 years, it has risen by +$92.72 million (+49.24%). VRNA annual working capital is now at all-time high.VRNA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$336.30 M
-$31.64 M-8.60%
30 September 2024
Summary:
Verona Pharma quarterly working capital is currently $336.30 million, with the most recent change of -$31.64 million (-8.60%) on 30 September 2024. Over the past year, it has increased by +$68.79 million (+25.71%). VRNA quarterly working capital is now -8.60% below its all-time high of $367.95 million, reached on 30 June 2024.VRNA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.5% | +25.7% |
| 3 y3 years | +49.2% | +114.5% |
| 5 y5 years | +260.4% | +615.0% |
VRNA Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +105.7% | -8.6% | +237.1% |
| 5 y | 5 years | at high | +577.9% | -8.6% | +1525.2% |
| alltime | all time | at high | >+9999.0% | -8.6% | >+9999.0% |
Verona Pharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $336.30 M(-8.6%) |
| June 2024 | - | $367.95 M(+43.1%) |
| Mar 2024 | - | $257.07 M(-8.5%) |
| Dec 2023 | $281.02 M(+25.5%) | $281.02 M(+5.0%) |
| Sept 2023 | - | $267.51 M(-3.4%) |
| June 2023 | - | $276.88 M(-1.2%) |
| Mar 2023 | - | $280.37 M(+25.2%) |
| Dec 2022 | $223.97 M(+63.9%) | $223.97 M(-1.0%) |
| Sept 2022 | - | $226.33 M(+126.9%) |
| June 2022 | - | $99.77 M(-13.3%) |
| Mar 2022 | - | $115.05 M(-15.8%) |
| Dec 2021 | $136.64 M(-27.4%) | $136.64 M(-12.8%) |
| Sept 2021 | - | $156.75 M(-0.7%) |
| June 2021 | - | $157.92 M(-10.2%) |
| Mar 2021 | - | $175.90 M(-6.6%) |
| Dec 2020 | $188.30 M(+354.2%) | $188.30 M(-3.7%) |
| Sept 2020 | - | $195.62 M(+845.3%) |
| June 2020 | - | $20.69 M(-28.4%) |
| Mar 2020 | - | $28.91 M(-30.3%) |
| Dec 2019 | $41.46 M(-46.8%) | $41.46 M(-11.9%) |
| Sept 2019 | - | $47.04 M(-22.9%) |
| June 2019 | - | $61.00 M(-17.0%) |
| Mar 2019 | - | $73.49 M(-5.7%) |
| Dec 2018 | $77.96 M(-26.5%) | $77.96 M(-6.0%) |
| Sept 2018 | - | $82.98 M(-2.8%) |
| June 2018 | - | $85.40 M(-5.0%) |
| Mar 2018 | - | $89.89 M(-15.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $106.06 M(+161.0%) | $106.06 M(-5.3%) |
| Sept 2017 | - | $112.02 M(-6.0%) |
| June 2017 | - | $119.17 M(+193.2%) |
| Dec 2016 | $40.64 M(+629.6%) | $40.64 M(+1232.6%) |
| June 2016 | - | $3.05 M(-45.2%) |
| Dec 2015 | $5.57 M(-66.7%) | $5.57 M(-52.2%) |
| June 2015 | - | $11.64 M(-30.3%) |
| Dec 2014 | $16.71 M(+2682.4%) | $16.71 M(-18.4%) |
| June 2014 | - | $20.47 M(+3309.3%) |
| Dec 2013 | $600.40 K(-61.7%) | $600.40 K(-59.0%) |
| June 2013 | - | $1.47 M(-6.4%) |
| Dec 2012 | $1.57 M(-59.0%) | $1.57 M(-59.2%) |
| June 2012 | - | $3.84 M(+0.6%) |
| Dec 2011 | $3.82 M(+32.7%) | $3.82 M(+123.0%) |
| June 2011 | - | $1.71 M(-40.5%) |
| Dec 2010 | $2.88 M(-39.1%) | $2.88 M(-34.5%) |
| June 2010 | - | $4.40 M(-7.0%) |
| Dec 2009 | $4.73 M(+32.4%) | $4.73 M(+70.9%) |
| June 2009 | - | $2.77 M(-22.5%) |
| Dec 2008 | $3.57 M(+34.8%) | $3.57 M(-39.5%) |
| June 2008 | - | $5.90 M(+122.7%) |
| Dec 2007 | $2.65 M(-42.5%) | $2.65 M(-30.2%) |
| June 2007 | - | $3.80 M(-17.6%) |
| Dec 2006 | $4.60 M(+173.3%) | $4.60 M(+179.0%) |
| June 2006 | - | $1.65 M(-2.0%) |
| Dec 2005 | $1.68 M | $1.68 M(-5.6%) |
| June 2005 | - | $1.78 M |
FAQ
- What is Verona Pharma annual working capital?
- What is the all time high annual working capital for Verona Pharma?
- What is Verona Pharma annual working capital year-on-year change?
- What is Verona Pharma quarterly working capital?
- What is the all time high quarterly working capital for Verona Pharma?
- What is Verona Pharma quarterly working capital year-on-year change?
What is Verona Pharma annual working capital?
The current annual working capital of VRNA is $281.02 M
What is the all time high annual working capital for Verona Pharma?
Verona Pharma all-time high annual working capital is $281.02 M
What is Verona Pharma annual working capital year-on-year change?
Over the past year, VRNA annual working capital has changed by +$57.05 M (+25.47%)
What is Verona Pharma quarterly working capital?
The current quarterly working capital of VRNA is $336.30 M
What is the all time high quarterly working capital for Verona Pharma?
Verona Pharma all-time high quarterly working capital is $367.95 M
What is Verona Pharma quarterly working capital year-on-year change?
Over the past year, VRNA quarterly working capital has changed by +$68.79 M (+25.71%)